Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2015 (2015), Article ID 896098, 4 pages
http://dx.doi.org/10.1155/2015/896098
Research Article

Clinical Manifestations of Herpes Zoster, Its Comorbidities, and Its Complications in North of Iran from 2007 to 2013

1Antimicrobial Resistance Research Center, Department of Infectious Diseases, Mazandaran University of Medical Sciences, Sari, Iran
2Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Received 22 December 2014; Revised 15 March 2015; Accepted 18 March 2015

Academic Editor: Mamede de Carvalho

Copyright © 2015 Farhang Babamahmoodi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. W. Johnson and R. H. Dworkin, “Treatment of herpes zoster and postherpetic neuralgia,” British Medical Journal, vol. 326, no. 7392, pp. 748–750, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. Z. Sharifi and S. Emadi Ghanjin, “The seroepidemiology of Varicella Zoster Virus (VZV) in different age groups in Tehran, Iran,” Iranian Journal of Allergy, Asthma and Immunology, vol. 4, no. 2, pp. 95–98, 2005. View at Google Scholar
  3. A. Volpi, A. Gatti, F. Pica, S. Bellino, L. T. Marsella, and A. F. Sabato, “Clinical and psychosocialcorrelates of post-herpeticneuralgia,” Journal of Medical Virology, vol. 80, no. 9, pp. 1646–1652, 2008. View at Publisher · View at Google Scholar
  4. W. Opstelten, J. W. Mauritz, N. J. de Wit, A. J. M. van Wijck, W. A. B. Stalman, and G. A. van Essen, “Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database,” Family Practice, vol. 19, no. 5, pp. 471–475, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. P. K. Wung, J. T. Holbrook, G. S. Hoffman et al., “Herpes zoster in immunocompromised patients: incidence, timing, and risk factors,” The American Journal of Medicine, vol. 118, no. 12, pp. 1416.e9–1416.e18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Pasqualucci, V. Pasqualucci, F. Galla et al., “Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone,” Acta Anaesthesiologica Scandinavica, vol. 44, no. 8, pp. 910–918, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. N. Oxman and M. J. Levin, “Vaccination against herpes zoster and postherpetic neuralgia,” The Journal of Infectious Diseases, vol. 197, supplement 2, pp. S228–S236, 2008. View at Google Scholar
  8. J. Katz, E. M. Cooper, R. R. Walther, E. W. Sweeney, and R. H. Dworkin, “Acute pain in herpes zoster and its impact on health-related quality of life,” Clinical Infectious Diseases, vol. 39, no. 3, pp. 342–348, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Banz, S. Wagenpfeil, A. Neiss et al., “The cost-effectiveness of routine childhood varicella vaccination in Germany,” Vaccine, vol. 21, no. 11-12, pp. 1256–1267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Pasqualucci, V. Pasqualucci, F. Galla et al., “Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone,” Acta Anaesthesiologica Scandinavica, vol. 44, no. 8, pp. 910–918, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Whitley, A. Volpi, M. McKendrick, A. van Wijck, and A. L. Oaklander, “Management of herpes zoster and post-herpetic neuralgia now and in the future,” Journal of Clinical Virology, vol. 48, supplement 1, pp. S20–S28, 2010. View at Publisher · View at Google Scholar
  12. M. Roxas, “Herpeszoster and postherpeticneuralgia: diagnosis and therapeutic considerations,” Alternative Medicine Review, vol. 11, no. 2, pp. 102–113, 2006. View at Google Scholar
  13. R. H. Dworkin, R. W. Johnson, J. Breuer et al., “Recommendations for the management of herpes zoster,” Clinical Infectious Diseases, vol. 44, supplement 1, pp. S1–S26, 2007. View at Publisher · View at Google Scholar
  14. L. Q. Araújo, C. R. Macintyre, and C. Vujacich, “Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America,” Herpes, vol. 14, supplement 2, pp. 40–44, 2007. View at Google Scholar · View at Scopus
  15. M. Brisson, W. J. Edmunds, B. Law et al., “Epidemiology of varicella zoster virus infection in Canada and the United Kingdom,” Epidemiology and Infection, vol. 127, no. 2, pp. 305–314, 2001. View at Google Scholar · View at Scopus
  16. R. P. Insinga, R. F. Itzler, J. M. Pellissier, P. Saddier, and A. A. Nikas, “The incidence of herpes zoster in a United States administrative database,” Journal of General Internal Medicine, vol. 20, no. 8, pp. 748–753, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. B. P. Yawn, P. Saddier, P. C. Wollan, J. L. St. Sauver, M. J. Kurland, and L. S. Sy, “A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction,” Mayo Clinic Proceedings, vol. 82, no. 11, pp. 1341–1349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. H. de Melker, G. Berbers, S. Hahné et al., “The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination,” Vaccine, vol. 24, no. 18, pp. 3946–3952, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Civen, S. S. Chaves, A. Jumaan et al., “The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination,” Pediatric Infectious Disease Journal, vol. 28, no. 11, pp. 954–959, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Colebunders, J. M. Mann, H. Francis et al., “Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection,” Journal of Infectious Diseases, vol. 157, no. 2, pp. 314–318, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. S. P. Buchbinder, M. H. Katz, N. A. Hessol et al., “Herpes zoster and human immunodeficiency virus infection,” Journal of Infectious Diseases, vol. 166, no. 5, pp. 1153–1156, 1992. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Schmader, L. K. George, B. M. Burchett, and C. F. Pieper, “Racial and psychosocial risk factors for herpes zoster in the elderly,” Journal of Infectious Diseases, vol. 178, supplement 1, pp. S67–S70, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Marin, D. Güris, S. S. Chaves, S. Schmid, and J. F. Seward, “Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP),” MMWR Recommendations and Reports, vol. 56, no. 4, pp. 1–40, 2007. View at Google Scholar
  24. A. Gatti, F. Pica, M. T. Y. Boccia, F. De Antoni, A. F. Sabato, and A. Volpi, “No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia,” Journal of Medical Virology, vol. 82, no. 6, pp. 1007–1011, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. L. Thomas and A. J. Hall, “What does epidemiology tell us about risk factors for herpes zoster?” The Lancet Infectious Diseases, vol. 4, no. 1, pp. 26–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. F. Seward, M. Marin, and M. Vázquez, “Varicella vaccine effectiveness in the US vaccination program: a review,” The Journal of Infectious Diseases, vol. 197, supplement 2, pp. S82–S89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Baxter, P. Ray, T. N. Tran et al., “Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study,” Pediatrics, vol. 131, no. 5, pp. e1389–e1396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Marin, H. C. Meissner, and J. F. Seward, “Varicella prevention in the United States: a review of successes and challenges,” Pediatrics, vol. 122, no. 3, pp. e744–e751, 2008. View at Publisher · View at Google Scholar · View at Scopus